blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1284273

EP1284273 - Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.08.2011
Database last updated on 24.04.2024
Most recent event   Tooltip02.09.2011Lapse of the patent in a contracting state
New state(s): DK		published on 05.10.2011  [2011/40]
Applicant(s)For all designated states
Sterix Limited
190 Bath Road
Slough, Berkshire SL1 3XE / GB
[2006/46]
Former [2003/40]For all designated states
Schering AG
Müllerstrasse 178
13353 Berlin / DE
Former [2003/08]For all designated states
JENAPHARM GmbH
Otto-Schott-Strasse 15
D-07745 Jena / DE
Inventor(s)01 / Schwarz, Sigfried
Ottogerd Mühlmann Strasse 17
D-07743 Jena / DE
02 / Walter, Elger
Schorlemerallee 12 b
D-14195 Berlin / DE
03 / Reddersen Gudrun
Hügelstr.25
D-07749 Jena / DE
04 / Schneider, Birgitt
Damaschkeweg 19
D-07745 Jena / DE
05 / Siemann, Hans-Joachim
Fritz Ritter ST.6
D-07747 Jena / DE
 [2010/12]
Former [2003/08]01 / Schwarz, Sigfried
Ottogerd Mühlmann Strabe 17
D-07743 Jena / DE
02 / Walter, Elger
Schorlemerallee 12 b
D-14195 Berlin / DE
03 / Reddersen Gudrun
Hügelstr.25
D-07749 Jena / DE
04 / Schneider, Birgitt
Damaschkeweg 19
D-07745 Jena / DE
05 / Siemann, Hans-Joachim
Fritz Ritter ST.6
D-07747 Jena / DE
Representative(s)Alcock, David, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2008/32]Alcock, David, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2008/01]Alcock, David, et al
D Young & Co 120 Holborn
London, EC1N 2DY / GB
Former [2006/46]Bradley, Adrian, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Former [2003/32]Ziebig, Marlene K., Dr., et al
Anwaltskanzlei, Gulde Hengelhaupt Ziebig & Schneider, Schützenstrasse 15-17
10117 Berlin / DE
Former [2003/25]Rasch, Dorit, et al
c/o Anwaltskanzlei, Gulde Hengelhaupt Ziebig & Schneider, Schützenstrasse 15-17
10117 Berlin / DE
Former [2003/08]Wablat, Wolfgang, Dr.Dr.
Patentanwalt, Potsdamer Chaussee 48
14129 Berlin / DE
Application number, filing date02090252.403.07.1995
[2003/08]
Priority number, dateDE1994442939709.08.1994         Original published format: DE 4429397
[2003/08]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1284273
Date:19.02.2003
Language:DE
[2003/08]
Type: A3 Search report 
No.:EP1284273
Date:21.07.2004
[2004/30]
Type: B1 Patent specification 
No.:EP1284273
Date:29.09.2010
Language:DE
[2010/39]
Search report(s)(Supplementary) European search report - dispatched on:EP08.06.2004
ClassificationIPC:C07J41/00, A61K31/56, C07J53/00, C07J43/00, C07J51/00, A61P5/30
[2004/30]
CPC:
C07J43/003 (EP,US); A61P15/00 (EP); A61P15/18 (EP);
A61P5/24 (EP); A61P5/26 (EP); A61P5/30 (EP);
A61P5/34 (EP); C07J41/0072 (EP,US); C07J51/00 (EP,US);
C07J53/004 (EP,US) (-)
Former IPC [2003/08]C07J41/00, C07J53/00, A61K31/565, A61K31/58, A61P5/30, A61P15/18, C07J43/00
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2003/08]
TitleGerman:Estra-1,3,5(10)-trien-3-sulfamat Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen[2003/08]
English:Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them[2003/08]
French:Dérivés Estra-1,3,5(10)-trien-3-sulfamates un procédé pour leur production et les compositions pharmaceutiques les conténant[2003/08]
Examination procedure15.07.2002Examination requested  [2003/08]
19.10.2007Despatch of a communication from the examining division (Time limit: M04)
28.01.2008Reply to a communication from the examining division
22.02.2010Communication of intention to grant the patent
22.06.2010Fee for grant paid
22.06.2010Fee for publishing/printing paid
Parent application(s)   TooltipEP95925679.3  / EP0775155
Opposition(s)30.06.2011No opposition filed within time limit [2011/36]
Fees paidRenewal fee
15.07.2002Renewal fee patent year 03
15.07.2002Renewal fee patent year 04
15.07.2002Renewal fee patent year 05
15.07.2002Renewal fee patent year 06
15.07.2002Renewal fee patent year 07
15.07.2002Renewal fee patent year 08
13.06.2003Renewal fee patent year 09
16.06.2004Renewal fee patent year 10
20.06.2005Renewal fee patent year 11
16.06.2006Renewal fee patent year 12
16.07.2007Renewal fee patent year 13
24.09.2008Renewal fee patent year 14
15.07.2009Renewal fee patent year 15
28.07.2010Renewal fee patent year 16
Penalty fee
Additional fee for renewal fee
31.07.200814   M06   Fee paid on   24.09.2008
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipDK29.09.2010
IE29.09.2010
IT29.09.2010
NL29.09.2010
SE29.09.2010
GR30.12.2010
ES09.01.2011
PT31.01.2011
[2011/40]
Former [2011/35]IE29.09.2010
IT29.09.2010
NL29.09.2010
SE29.09.2010
GR30.12.2010
ES09.01.2011
PT31.01.2011
Former [2011/31]IT29.09.2010
NL29.09.2010
SE29.09.2010
GR30.12.2010
PT31.01.2011
Former [2011/24]NL29.09.2010
SE29.09.2010
GR30.12.2010
PT31.01.2011
Former [2011/15]SE29.09.2010
GR30.12.2010
Documents cited:Search[Y]DE1949095  (JENAPHARM VEB) [Y] 1-4 * page 3, line 9 - line 18; examples 27-29 *;
 [Y]US3697558  (BACH NICHOLAS J, et al) [Y] 1-4 * column 1, paragraph 1 *;
 [Y]FR2133484  (JENAPHARM VEB [DD]) [Y] 1-4 * page 2, line 14 - line 18; examples 21-23,25,27 *;
 [Y]DD114806  (S. SCHWARTZ) [Y] 1-4 * page 2, column 1, line 52 - line 59; examples 2-4,6,9,10 *;
 [Y]DD201143  (SCHWARZ SIGFRID, et al) [Y] 1-4 * page 1, lines 6-8; examples 3-5 *;
 [Y]US4656142  (JAOUEN GERARD [FR], et al) [Y] 1-4 * claim 3 *;
 [Y]  - SCHWARZ S ET AL, "Steroids. XI. 17.alpha.-Ethynylestradiol sulfamates", Z. CHEM., (1970), vol. 10, no. 8, pages 299 - 300, XP008030936 [Y] 1-4 * the whole document *
 [Y]  - SCHWARZ S ET AL, "Steroids. 15. Sulfonyloxy derivatives of estrogens", PHARMAZIE, BERLIN DE, (1975), vol. 30, no. 1, pages 17 - 21, XP002026378 [Y] 1-4 * siehe verbindungen 18-25, 28-32, 59-62, 80, 81 und 110-113 *
 [Y]  - STOELZNER W ET AL, "Dissociation of the antigonadotrophic and the contraceptive activities of certain estratriene derivatives", PHARMAZIE, BERLIN DE, (1975), vol. 30, no. 1, pages 52 - 53, XP002026377 [Y] 1-4 * the whole document *
 [Y]  - J. REYNOLDS, MARTINDALE, LONDON (UK), THE PHARMACEUTICAL PRESS, (1989), 29, XP002282219 [Y] 1-4 * page 1408, column 3, paragraph L - page 1409, column 1, paragraph 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.